Albert D. Bolt v. Merrimack Pharmaceuticals, Inc.
United States Court of Appeals for the Ninth Circuit
503 F.3d 913 (2007)
- Written by Eric Miller, JD
Facts
Albert D. Bolt (plaintiff) owned 52,488 shares of Series A redeemable preferred stock in Merrimack Pharmaceuticals, Inc. (Merrimack) (defendant). Merrimack’s restated articles of incorporation specified that its Series A shares were redeemable if the company’s net worth equaled or exceeded $5 million at the end of the most recent fiscal quarter as determined through generally accepted accounting principles (GAAP). Bolt sought to redeem his shares in April 2001 and March 2002, but Merrimack rejected his requests. As of December 31, 2001, Merrimack’s balance sheet showed total assets of $11,331,070 and total liabilities of $1,270,230. A professional accounting firm deemed these and other Merrimack financial statements to be in accordance with GAAP. Bolt brought suit in federal district court, seeking a declaratory judgment that Merrimack’s net worth was more than $5 million. Merrimack argued that it defined net worth as stockholders’ equity, which was at a deficit of $2,402,807, but this definition did not appear in the restated articles of incorporation. The court concluded that Merrimack’s net worth exceeded $5 million and granted summary judgment in favor of Bolt. Merrimack appealed. The United States Court of Appeals for the Ninth Circuit granted certiorari.
Rule of Law
Issue
Holding and Reasoning (O’Scannlain, J.)
What to do next…
Here's why 780,000 law students have relied on our case briefs:
- Written by law professors and practitioners, not other law students. 46,200 briefs, keyed to 988 casebooks. Top-notch customer support.
- The right amount of information, includes the facts, issues, rule of law, holding and reasoning, and any concurrences and dissents.
- Access in your classes, works on your mobile and tablet. Massive library of related video lessons and high quality multiple-choice questions.
- Easy to use, uniform format for every case brief. Written in plain English, not in legalese. Our briefs summarize and simplify; they don’t just repeat the court’s language.